MENLO PARK, Calif.--(BUSINESS WIRE)--Sept. 6, 2006--Geron Corporation (Nasdaq:GERN) today announced the dismissal of appeals of two patent interference decisions pending before the U.S. District Court for the District of Columbia and relating to patents covering nuclear transfer (cloning) technology.
